TI
PVLA

Trexquant Investment’s Palvella Therapeutics PVLA Stock Holding History

Trexquant Investment’s Portfolio PVLA Stock Details PVLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.57M Buy
+36,639
New +$3.82M 0.03% 685
2018
Q4 		– Sell
-612
Closed -$274K – 1355
2018
Q3 		$274K Buy
612
+333
+119% +$145K 0.02% 716
2018
Q2 		$113K Sell
279
-864
-76% -$411K 0.01% 831
2018
Q1 		$624K Buy
1,143
+646
+130% +$400K 0.04% 560
2017
Q4 		$300K Buy
+497
New +$231K 0.03% 749

Other funds holding PVLA

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Trexquant Investment's PVLA Position: Q1 2026 in Review

Trexquant Investment opened a new position in Palvella Therapeutics (PVLA) in Q1 2026: 36,639 shares worth $4.57M. The stake represents 0.03% of the portfolio and ranks #685 among its holdings. This is a return to the name: Trexquant Investment previously reported a position in PVLA as recently as Q3 2018.

Trexquant Investment first reported a position in PVLA in Q4 2017 and has held it in 5 quarters since. 180 funds tracked by Wall St. Rank hold PVLA as of Q1 2026.

  • Trexquant Investment held 36,639 shares of Palvella Therapeutics worth $4.57M as of Q1 2026.
  • Palvella Therapeutics was a new Trexquant Investment position in Q1 2026.
  • Palvella Therapeutics made up 0.03% of Trexquant Investment's portfolio in Q1 2026, its #685 holding.
  • Trexquant Investment first reported a position in Palvella Therapeutics in Q4 2017 and has held it in 5 quarters since.
  • 180 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q1 2026.

Based on Trexquant Investment's 13F filing for Q1 2026, filed 15 May 2026.